Human Kinase Akt1 / PKB alpha Inactive Enzyme Protein

Este producto es parte de AKT1 - RAC-alpha serine/threonine-protein kinase 1
Product Graph
650€ (5 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Kinase Akt1 / PKB alpha Inactive Enzyme Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx073029
tested applications
SDS-PAGE

Description

Human Protein Kinase Akt1/PKB alpha Inactive Enzyme Protein is a recombinant protein kinases.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Kinase Akt1 / PKB alpha Inactive
Host
Insect
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Origin
Human
Expression
Recombinant
Purity
> 90% (SDS-PAGE)
Size 1
5 µg
Size 2
20 µg
Size 3
40 µg
Form
Liquid
Tested Applications
SDS-PAGE
Availability
Shipped within 5-10 working days.
Storage
Store at 4 °C if the entire vial will be used within 4 weeks. Store at -20 °C for long term storage. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P31749
Alias
AKT1,PKB,RAC,RAC-ALPHA
Background
Protein AKT1
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

The AKT (also known as Protein Kinase B) is a pivotal enzyme involved in regulating various cellular processes like metabolism, proliferation, survival, and growth. It acts downstream of phosphoinositide 3-kinase (PI3K) signaling pathway, which is activated by growth factors and cytokines. RAC-alpha serine/threonine-protein kinase is the full name of AKT. It belongs to the AGC (protein kinase A/protein kinase G/protein kinase C) family of kinases. AKT has three isoforms: AKT1, AKT2, and AKT3. Each isoform has slightly different tissue distributions and roles but shares the same basic structure and mechanism of action.Activation of AKT typically occurs through phosphorylation at two key residues: threonine 308 (Thr308) and serine 473 (Ser473). Once activated, AKT phosphorylates various downstream targets, including transcription factors, metabolic enzymes, and cell cycle regulators, ultimately leading to diverse cellular responses. Dysregulation of AKT signaling is implicated in various diseases, including cancer, diabetes, and cardiovascular diseases. Therefore, AKT has emerged as a significant target for therapeutic interventions in these conditions.

Related Products

EH0532

Human AKT1 (RAC-alpha serine/threonine-protein kinase) ELISA Kit

Ver Producto
EM1294

Mouse AKT1 (RAC-alpha serine/threonine-protein kinase) ELISA Kit

Ver Producto
ER1268

Rat AKT1 (RAC-alpha serine/threonine-protein kinase) ELISA Kit

Ver Producto